Insulet Price to Book Ratio 2010-2025 | PODD
Historical price to book ratio values for Insulet (PODD) over the last 10 years. The current price to book ratio for Insulet as of July 03, 2025 is 15.95.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Insulet Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-03 | 301.05 | 15.92 | |
| 2025-03-31 | 262.61 | $18.91 | 13.89 |
| 2024-12-31 | 261.07 | $17.26 | 15.13 |
| 2024-09-30 | 232.75 | $15.94 | 14.60 |
| 2024-06-30 | 201.80 | $14.24 | 14.17 |
| 2024-03-31 | 171.40 | $11.29 | 15.18 |
| 2023-12-31 | 216.98 | $10.48 | 20.70 |
| 2023-09-30 | 159.49 | $8.70 | 18.33 |
| 2023-06-30 | 288.34 | $7.94 | 36.34 |
| 2023-03-31 | 318.96 | $7.21 | 44.21 |
| 2022-12-31 | 294.39 | $6.85 | 42.95 |
| 2022-09-30 | 229.40 | $6.16 | 37.21 |
| 2022-06-30 | 217.94 | $6.09 | 35.80 |
| 2022-03-31 | 266.39 | $6.44 | 41.34 |
| 2021-12-31 | 266.07 | $8.04 | 33.09 |
| 2021-09-30 | 284.23 | $7.22 | 39.34 |
| 2021-06-30 | 274.51 | $6.69 | 41.02 |
| 2021-03-31 | 260.92 | $8.84 | 29.52 |
| 2020-12-31 | 255.63 | $9.14 | 27.96 |
| 2020-09-30 | 236.59 | $9.03 | 26.19 |
| 2020-06-30 | 194.26 | $8.59 | 22.62 |
| 2020-03-31 | 165.68 | $0.94 | 177.08 |
| 2019-12-31 | 171.20 | $1.21 | 141.39 |
| 2019-09-30 | 164.93 | $2.44 | 67.68 |
| 2019-06-30 | 119.38 | $4.15 | 28.75 |
| 2019-03-31 | 95.09 | $3.75 | 25.36 |
| 2018-12-31 | 79.32 | $3.58 | 22.14 |
| 2018-09-30 | 105.95 | $3.35 | 31.62 |
| 2018-06-30 | 85.70 | $3.04 | 28.21 |
| 2018-03-31 | 86.68 | $2.90 | 29.84 |
| 2017-12-31 | 69.00 | $2.72 | 25.39 |
| 2017-09-30 | 55.08 | $1.28 | 43.14 |
| 2017-06-30 | 51.31 | $1.12 | 46.01 |
| 2017-03-31 | 43.09 | $1.10 | 39.25 |
| 2016-12-31 | 37.68 | $1.10 | 34.28 |
| 2016-09-30 | 40.94 | $1.13 | 36.11 |
| 2016-06-30 | 30.24 | $0.48 | 63.08 |
| 2016-03-31 | 33.16 | $0.46 | 71.74 |
| 2015-12-31 | 37.81 | $0.60 | 63.24 |
| 2015-09-30 | 25.91 | $0.97 | 26.75 |
| 2015-06-30 | 30.99 | $1.24 | 25.09 |
| 2015-03-31 | 33.35 | $1.42 | 23.42 |
| 2014-12-31 | 46.06 | $1.49 | 30.93 |
| 2014-09-30 | 36.85 | $1.43 | 25.70 |
| 2014-06-30 | 39.67 | $1.40 | 28.27 |
| 2014-03-31 | 47.42 | $2.22 | 21.39 |
| 2013-12-31 | 37.10 | $2.27 | 16.34 |
| 2013-09-30 | 36.24 | $2.23 | 16.27 |
| 2013-06-30 | 31.41 | $2.55 | 12.34 |
| 2013-03-31 | 25.86 | $2.43 | 10.64 |
| 2012-12-31 | 21.22 | $0.91 | 23.23 |
| 2012-09-30 | 21.58 | $1.05 | 20.58 |
| 2012-06-30 | 21.37 | $1.23 | 17.33 |
| 2012-03-31 | 19.14 | $1.47 | 13.01 |
| 2011-12-31 | 18.83 | $1.74 | 10.81 |
| 2011-09-30 | 15.26 | $1.76 | 8.67 |
| 2011-06-30 | 22.17 | $1.99 | 11.13 |
| 2011-03-31 | 20.62 | $1.30 | 15.81 |
| 2010-12-31 | 15.50 | $1.46 | 10.63 |
| 2010-09-30 | 14.14 | $0.83 | 16.95 |
| 2010-06-30 | 15.05 | $1.10 | 13.73 |
| 2010-03-31 | 15.09 | $1.08 | 13.99 |
| 2009-12-31 | 14.28 | $1.64 | 8.71 |
| 2009-09-30 | 11.23 | $0.01 | 1145.92 |
| 2009-06-30 | 7.70 | $-0.12 | -61.90 |
| 2009-03-31 | 4.10 | $0.56 | 7.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.226B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.329B | 28.06 |
| Boston Scientific (BSX) | United States | $153.315B | 38.38 |
| Stryker (SYK) | United States | $149.550B | 31.27 |
| EssilorLuxottica (ESLOY) | France | $129.320B | 0.00 |
| Medtronic (MDT) | Ireland | $113.223B | 16.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.111B | 26.31 |
| ResMed (RMD) | United States | $37.519B | 28.18 |
| GE HealthCare Technologies (GEHC) | United States | $34.854B | 16.55 |
| Agilent Technologies (A) | United States | $34.275B | 22.34 |
| Terumo (TRUMY) | Japan | $25.791B | 33.50 |
| Koninklijke Philips (PHG) | Netherlands | $23.611B | 16.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.499B | 11.88 |
| Baxter (BAX) | United States | $15.975B | 11.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.209B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.821B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $3.962B | 17.70 |
| Perrigo (PRGO) | Ireland | $3.748B | 9.50 |
| Haemonetics (HAE) | United States | $3.663B | 16.68 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.419B | 28.41 |
| ICU Medical (ICUI) | United States | $3.352B | 24.72 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.894B | 42.35 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 12.84 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Neogen (NEOG) | United States | $1.135B | 14.53 |
| Phibro Animal Health (PAHC) | United States | $1.133B | 14.48 |
| BioLife Solutions (BLFS) | United States | $1.081B | 0.00 |
| InMode (INMD) | Israel | $0.961B | 9.69 |
| Kestra Medical Technologies (KMTS) | United States | $0.783B | 0.00 |
| Owens & Minor (OMI) | United States | $0.718B | 5.96 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| CeriBell (CBLL) | United States | $0.673B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.458B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 23.60 |
| ZimVie (ZIMV) | United States | $0.279B | 12.67 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.266B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 74.50 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 64.00 |
| Biote (BTMD) | United States | $0.229B | 6.45 |
| OraSure Technologies (OSUR) | United States | $0.229B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.73 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 56.86 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.81 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |